Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease
NCT01157156
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Arterial Occlusive Disease
Interventions
DRUG:
XRP0038 (NV1FGF)
Sponsor
Sanofi